Enhancement of herpesvirus infection has been reported in cells competent for Human type I interferons (IFN) induction upon VPA treatment in a process associated with the VPA-mediated inhibition of type I histone deacetylases (HDAC) [19,20,21]. This evidence concerns the gene IFNA1 and Herpesviridae infectious disease.